Influenza vaccination influencing level of specific humoral immunity in healthy individuals

Influenza vaccination influencing level of specific humoral immunity in healthy individuals

To assess an effect of vaccination on the level of humoral anti-influenza herd immunity, 2955 sera were collected and analyzed by HIT in the 2019–2020 and 2020–2021 epidemiological seasons. All sera were obtained from healthy adult donors residing in various cities of the Russian Federation. Among t...

Full description

Bibliographic Details
Main Authors:	V. Z. Krivitskaya, E. V. Kuznecova, V. G. Maiorova, E. R. Petrova, A. A. Sominina, D. M. Danilenko
Format:	Article
Language:	Russian
Published:	Sankt-Peterburg : NIIÈM imeni Pastera 2022-01-01
Series:	Инфекция и иммунитет
Subjects:	vaccination anti-influenza immunity herd immunity hemagglutination inhibition test inactivated influenza vaccine vaccine strains
Online Access:	https://iimmun.ru/iimm/article/viewFile/1750/1439

Similar Items

T Cell Transcriptional Signatures of Influenza A/H3N2 Antibody Response to High Dose Influenza and Adjuvanted Influenza Vaccine in Older Adults
by: Iana H. Haralambieva, et al.
Published: (2022-12-01)

Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season
by: Zh. V. Buzitskaya, et al.
Published: (2023-06-01)

Month of Influenza Virus Vaccination Influences Antibody Responses in Children and Adults
by: Rhiannon R. Penkert, et al.
Published: (2021-01-01)

Humoral immunity to influenza and severe influenza cases in Russia in 2018-2019
by: T. N. Ilyicheva, et al.
Published: (2020-01-01)

Microneutralization reaction compared to hemagglutination inhibition assay to evaluate immunogenicity of influenza vaccines and influenza diagnostics
by: V. Z. Krivitskaya, et al.
Published: (2020-02-01)

Longitudinal Assessment of Immune Responses to Repeated Annual Influenza Vaccination in a Human Cohort of Adults and Teenagers
by: Meng-Hsuan Sung, et al.
Published: (2021-03-01)

Policy perspectives on post pandemic influenza vaccination in Ghana and Malawi
by: Evanson Z. Sambala, et al.
Published: (2017-02-01)

Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine
by: Huakun Lv, et al.
Published: (2021-11-01)

Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test
by: Seung Youn Kim, et al.
Published: (2012-12-01)

Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics
by: Kaori Sano, et al.
Published: (2018-08-01)

Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness
by: Ziyan Meng, et al.
Published: (2020-11-01)

2019–2020 herd immunity to seasonal influenza viruses prior to epidemic season and rate of severe disease cases
by: T. N. Ilyicheva, et al.
Published: (2021-11-01)

T-cell-mediated cross-strain protective immunity elicited by prime–boost vaccination with a live attenuated influenza vaccine
by: Junwei Li, et al.
Published: (2014-10-01)

Influenza vaccine failure: failure to protect or failure to understand?
by: Gregory A. Poland
Published: (2018-06-01)

Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
by: Olivia A. Vogel, et al.
Published: (2020-02-01)

Report from enhanced safety surveillance of two influenza vaccines (Vaxigrip and Intanza 15 μg) in two European countries during influenza season 2016/17 and comparison with 2015/16 season
by: Anne Laure Chabanon, et al.
Published: (2018-02-01)

Highly reproductive attenuated H2N2 and H7N9 reassortants on the basis of A/Hong Kong/1/68/162/35 donor virus
by: I. G. Vidyaeva, et al.
Published: (2016-12-01)

Determining optimal community protection strategies for the influenza vaccine
by: Charlotte Switzer, et al.
Published: (2019-08-01)

Effectiveness of trivalent inactivated influenza vaccines in children during 2017–2018 season in Korea: Comparison of test-negative analysis by rapid and RT-PCR influenza tests
by: Young Joo Sohn, et al.
Published: (2020-10-01)

Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan
by: Gulbanu Sarsenbayeva, et al.
Published: (2020-08-01)

Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis
by: Giulia Perego, et al.
Published: (2021-09-01)

Excessive daytime sleepiness is associated with impaired antibody response to influenza vaccination in older male adults
by: Huy Quang Quach, et al.
Published: (2023-12-01)

Influenza Virus and Vaccination
by: Aitor Nogales, et al.
Published: (2020-03-01)

Factors affecting the immunogenicity of influenza vaccines in human
by: Qiuyi Xu, et al.
Published: (2023-04-01)

Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents
by: Eun Kyeong Kang, et al.
Published: (2017-04-01)

Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine
by: Marc Demeulemeester, et al.
Published: (2017-04-01)

Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
by: Alexander W Kay, et al.
Published: (2015-06-01)

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
by: Nijalingappa K. Kalappanavar, et al.
Published: (2022-11-01)

Protection of children against influenza: Emerging problems
by: Nicola Principi, et al.
Published: (2018-03-01)

An approximation of herd effect due to vaccinating children against seasonal influenza – a potential solution to the incorporation of indirect effects into static models
by: Van Vlaenderen Ilse, et al.
Published: (2013-01-01)

Evaluation of determinants of the serological response to the quadrivalent split‐inactivated influenza vaccine
by: Shaohuan Wu, et al.
Published: (2022-05-01)

Serological Evidence of Backyard Pig Exposure to Highly Pathogenic Avian Influenza H5N8 Virus during 2016–2017 Epizootic in France
by: Séverine Hervé, et al.
Published: (2021-05-01)

Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18–60 years of age in the Republic of Korea
by: Won Suk Choi, et al.
Published: (2018-03-01)

Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
by: Viviane Gresset-Bourgeois, et al.
Published: (2018-01-01)

Influenza Vaccine Effectiveness Estimates among US Department of Defense Adult Beneficiaries over Four Consecutive Influenza Seasons: A Test-Negative Design Study with Different Control Groups
by: Wenping Hu, et al.
Published: (2021-12-01)

The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations
by: Kristin B. Wiggins, et al.
Published: (2021-06-01)

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
by: Mariia V. Sergeeva, et al.
Published: (2023-11-01)

Awareness of Influenza and Pneumococcal Vaccination in the Geriatric Age Group
by: Süheyla AYDOĞMUŞ, et al.
Published: (2010-12-01)

The cellular and humoral immune response to influenza vaccination is comparable in asthmatic and healthy subjects
by: Andrea Aida Velasco-Medina, et al.
Published: (2021-01-01)

Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children
by: Jann Catherine Ang, et al.
Published: (2019-08-01)